Results - Financial Year Sept 30, 2018
We refer to our letter dated 16th October 2018 informing you of our Board Meeting that was scheduled today. The Meeting of Board of Directors commenced at 12 noon and concluded at 3.30 p.m. The Board approved unaudited financial results for the quarter ended 30th September 2018. We enclose a copy of the unaudited financial results of the quarter ended 30th September 2018 approved at this Meeting and the Limited Review Report as required... Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 30Th September 2018
Pursuant to Regulation 40 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith Certificate of M/s. S. N. Ananthasubramanian & Co., Company Secretaries for the half year ended 30th September 2018. Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed copies of the Notice of the Board Meeting of the Company published today, in newspapers, Business Standard and Sakal. Shareholding for the Period Ended September 30, 2018
Sanofi India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here Statement Of Investor Complaints For The Quarter Ended September 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 1560 Name of the Signatory :- GIRISH TEKCHANDANIDesignation :- Company Secretary and Compliance Officer Compliance Certificate For The Period Ended 30Th September, 2018
As required under Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility were maintained during the period 1st April 2018 to 30th September 2018 (both days inclusive) by the Company's Registrar and Share Transfer Agent, viz., Link Intime India Private Limited, which is registered as Registrar & Share Transfer... Announcement under Regulation 30 (LODR)-Press Release / Media Release
We enclose herewith a copy of press release - Combiflam Range of Pain Relief Solutions introduces Pain Education Campaign in Bihar, contents of which are self-explanatory for your information and records. Sanofi Pasteur readies pipeline of 11 vaccines for RSV, hepatitis A, herpes
Sanofi had acquired Shantha Biotechnics in 2009, which makes vaccines for the company in India Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed copies of the Notice to Members of the Company published today, in newspapers, Business Standard and Sakal. Announcement under Regulation 30 (LODR)-Press Release / Media Release
We enclose herewith a copy of press release - 26 young people with type 1 diabetes successfully surmount 13,000 ft., in 'India's 2nd T1D Challenge 2018' , contents of which are self-explanatory for your information and records.